Hoan My Medical Group and Gene Solutions Sign Strategic Partnership: Expanding Access to International-Standard Genetic Testing
Ho Chi Minh City, October 15, 2025 – Hoan My Medical Group and Gene Solutions held a strategic partnership signing ceremony, attended by Ms. Huynh Bich Lien, Chief Executive Officer of Hoan My Medical Group, and Dr. Nguyen Huu Nguyen, Co-founder and Deputy CEO of Gene Solutions, along with senior representatives from both organizations. This […]
Gene Solutions Showcases MRD and Multi-Omics Advances at Singapore Society of Oncology Annual Scientific Meeting 2025
Gene Solutions hosted a landmark symposium titled “Advancing Precision Oncology: Molecular Residual Disease (MRD) and Multi-Omics in Solid Tumors” at the Singapore Society of Oncology (SSO) Annual Scientific Meeting, held in Singapore on October 14, 2025. The event convened leading oncologists and researchers to explore how circulating tumor DNA (ctDNA)- based -MRD and multi-omics are […]
Clinical Case: Outsmarting Breast Cancer with Multi-Omics ctDNA
Overview Breast cancer is the second most common cancer worldwide, accounting for more than 600,000 deaths annually (1). Despite remarkable advances in early detection and treatment—leading to a 99% survival rate when diagnosed at an early stage—late detection and limited access to advanced therapies continue to make breast cancer one of the leading causes of […]
Gene Solutions to Present at IASLC Asia Conference on Lung Cancer (ACLC) 2025: Empower Cancer Care with Advanced Multi-omics & AI
Ho Chi Minh City, Vietnam – October 8, 2025 — Gene Solutions is honored to contribute to the IASLC Asia Conference on Lung Cancer (ACLC) 2025 with the presentation of five scientific abstracts, underscoring our continued commitment to innovation in lung cancer care. The International Association for the Study of Lung Cancer (IASLC) is the […]
Gene Solutions and AMPATH Launch Advanced Genomics Laboratory in Hyderabad to Expand Access to Precision Medicine in India
Hyderabad, India – Oct 2025 — Gene Solutions, a leading genetic testing innovator in Asia, has partnered with AMPATH (American Institute of Pathology and Laboratory Sciences), a trusted provider of high-quality diagnostic services in India, to open a new advanced genomics laboratory in Hyderabad. This collaboration aims to bring high-value, next-generation sequencing (NGS) technologies closer […]
Gene Solutions’ HRD Insight Expands PARP Inhibitor Access for Ovarian Cancer Patients
First-of-its-kind study reveals high HRD prevalence in Vietnamese ovarian cancer patients and validates the performance of HRD Insight assay. Gene Solutions today announced the publication of a peer-reviewed study in Frontier in Oncology validating the company’s HRD Insight assay, a novel protocol design to detect recombination deficiency (HRD) in ovarian cancer. The study demonstrates the […]
Gene Solutions to Spotlight MRD and Multi-Omics at SSO ASM 2025 in Singapore
Singapore, September 2025 – Gene Solutions will host an exclusive symposium titled “Advancing Precision Oncology: MRD and Multi-Omics in Solid Tumors” during the 10th Annual Scientific Meeting of the Singapore Society of Oncology (SSO ASM 2025). The session will take place on Saturday, October 4, 2025, from 09:15 to 10:00 AM (GMT+8) at Grand Ballroom […]
Gene Solutions Announces SPOT MAS Multi-omic Dataset on 75 Cancer Subtypes
Singapore, 26 September 2025 SPOT-MAS is Gene Solutions’ AI-powered cfDNA platform for multi-cancer early detection (MCED) and tumor-of-origin (TOO) localization across 10 cancer groups—integrating genetics, epigenetics, and fragmentomics in one streamlined workflow. Validated across multiple cancer types, the company today unveils the breadth of its multi-omic dataset, encompassing 75 cancer subtypes. This dataset provides deeper molecular and pathological intelligence, with the potential to enhance detection performance, as suggested by […]
New BMC Biology study shows SPOT-MAS multi-omics cfDNA distinguishes early-stage breast cancer from benign lesions with high specificity.
The Gene Solutions research team, in collaboration with Ho Chi Minh City Oncology Hospital and several oncology centers, has published new peer-reviewed data in BMC Biology demonstrating that a multimodal analysis of plasma cell-free DNA (cfDNA) can accurately differentiate early-stage breast cancer from benign breast conditions (e.g., fibroadenoma)—a frequent real-world challenge that often leads to […]
Gene Solutions at TOTIO 2025 – Driving Innovation in Cancer Care
Udaipur, India – August 22–24, 2025 – Gene Solutions participated in the prestigious TOTIO 2025 Conference, where Dr. Nguyen Duy Sinh, Oncology Medical Director at Gene Solutions, presented groundbreaking clinical validation data and AI-driven circulating tumor DNA (ctDNA) technologies to over 200 oncology experts dedicated to multidisciplinary cancer care and research. In his presentation titled “ctDNA and […]